CRISPR

Pharma IQ looks at the five most profitable pharma companies of 2022 so far

CRISPR therapy shows promise as a cure for severe sickle cell disease

Find out how the CRISPR market is developing and why it's influential to the world as we know it.

International researchers have developed a new CRISPR tool, Cas3, likened to a "DNA shredder with a motor"

You may remember reading Regina's previous article about immuno-oncology in 2018. Regina is back again to discuss key developments in gene editing and heart failure devices.Gene Editing - CRISPR Techn...

[inlinead]CRISPR has attracted media attention this year charting potential patent disputes where fortunes could be at stake. Three key heavyweights said to be at the centre of these IP discussions ar...

A new research report from Grand View Research inc, charts that the international epigenetics market is due to reach US$16.31 billion by 2022. The forecasted growth being fuelled by the increasing f...

The CRISPR Cas9 tool has attracted worldwide attention from the R&D industry in regards to its capabilities for gene editing.   The cutting edge method is being used to revolutionize re...

The trailblazing CRISPR Cas9 technique has vastly widened the gene editing horizons for the R&D industry. The technique has been gaining popularity since its inception in 2013, with some job adver...

Pharma IQ spoke to Bhuvaneish T. Selvaraj, a Post Doctorate Fellow in neurodegenerative disorders, to discover more about his ongoing CRISPR Cas9 project. [inlinead]...

The CRISPR tool has attracted worldwide attention from the R&D industry in regards to its capabilities for gene editing.CRISPR alongside the use of the Cas9 protein enables the ability to target a...

 Pharma IQ invites you to take part in our short survey, due to feature in our 2015 CRISPR Research Report in preparation for the Gene Editing CRISPR Summit taking place from 7th - 9th December...